Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anxiety Disorders × nabiximols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 7 Neoplasms 7 Marijuana Abuse 5 Cancer Pain 4 Glioblastoma 2 Squamous Cell Carcinoma of Head and Neck 1 Signs and Symptoms 1 Recurrence 1 Parasomnias 1 Pancreatic Neoplasms 1 Neuralgia 1 Nausea 1 Multiple Sclerosis 1 Mouth Neoplasms 1 Marijuana Use 1 Diabetes Mellitus 1 Chronic Pain 1 Cachexia 1 Breast Neoplasms 1 Brain Neoplasms 1 Anxiety Disorders 1 Anorexia 1 Advanced Malignant Solid Tumor 1 Advanced Cancer 1 1- Cancer Patients During Chemotherapy Treatment 1

Interventions

Music Therapy 12 Cognitive Behavioral Therapy 11 Therapeutics 10 Psychiatric Rehabilitation 10 Surveys and Questionnaires 9 Standard of Care 8 Methods 8 Educational Status 7 Early Intervention, Educational 7 Psilocybin 6 Ketamine 6 Hypnosis 6 Control Groups 6 Acupuncture Therapy 6 Mindfulness 5 Art Therapy 5 Aromatherapy 5 Saline Solution 4 Mindfulness-Based Cognitive Therapy 4 Interviews as Topic 4 Esketamine 4 Counseling 4 Behavior Therapy 4 Yoga 3 Weights and Measures 3 Touch 3 Therapeutic Touch 3 Palliative Care 3 Niacin 3 Mindfulness-Based Stress Reduction 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡